Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
COLL compared with ANDE: revenue, margins and what each company keeps, and the suppliers and customers both name
COLL
Collegium Pharmaceutical, Inc
Change
Mkt cap
Revenue
Revenue
ANDE
Andersons, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
COLL
Collegium Pharmaceutical, Inc
vs
ANDE
Andersons, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only COLL
2
—
Hikma Pharmaceuticals USA
unlisted
supplier
—
Grünenthal
unlisted
supplier
Shared
0
No disclosed counterparties: ANDE.
Only ANDE
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
COLL
Collegium Pharmaceutical, Inc
Change
23.84
▲
+0.67%
Mkt cap
$770.9M
Revenue
$200M
Q2 FY26
Revenue
$781M
FY25
ANDE
Andersons, Inc.
Change
62.78
▼
−1.87%
Regular session
Nov 3 '26
Mkt cap
$2.2B
Revenue
$3.1B
Q2 FY26
Revenue
$11.0B
FY25
vs
Compare
Regular session
Nov 3 '26
COLL
Collegium Pharmaceutical, Inc
vs
ANDE
Andersons, Inc.
23.84
▲
+0.67%
Price
62.78
▼
−1.87%
$770.9M
Mkt cap
$2.2B
Q2 FY26
$200M
Revenue
$3.1B
Q2 FY26
FY25
$781M
Revenue
$11.0B
FY25
Change
Change
COLL
23.84
▲
+0.67%
vs
ANDE
62.78
▼
−1.87%
Regular session
Nov 3 '26